| Published Application/Species/Sample/Dilution | Reference |
|---|
| Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher |
| Zhang X, Zheng B, Zhao L, Shen J, Yang Z, Zhang Y, et al. KLF4-PFKFB3-driven glycolysis is essential for phenotypic switching of vascular smooth muscle cells. Commun Biol. 2022;5:1332 pubmed publisher |
| Kitai H, Kato N, Ogami K, Komatsu S, Watanabe Y, Yoshino S, et al. Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis. BMC Biol. 2022;20:248 pubmed publisher |
| Vijayakumar B, Boustani K, Ogger P, Papadaki A, Tonkin J, Orton C, et al. Immuno-proteomic profiling reveals aberrant immune cell regulation in the airways of individuals with ongoing post-COVID-19 respiratory disease. Immunity. 2022;55:542-556.e5 pubmed publisher |
| Ugawa M, Kawamura Y, Toda K, Teranishi K, Morita H, Adachi H, et al. In silico-labeled ghost cytometry. elife. 2021;10: pubmed publisher |
| Lu J, Sun K, Yang H, Fan D, Huang H, Hong Y, et al. Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors. Front Immunol. 2021;12:732612 pubmed publisher |
| Georgakis S, Gkirtzimanaki K, Papadaki G, Gakiopoulou H, Drakos E, Eloranta M, et al. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE. JCI Insight. 2021;6: pubmed publisher |
| Thompson E, Cascino K, Ordonez A, Zhou W, Vaghasia A, Hamacher Brady A, et al. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients. Cell Rep. 2021;34:108863 pubmed publisher |
| González Tajuelo R, González Sánchez E, Silván J, Muñoz Callejas A, Vicente Rabaneda E, Garcia Perez J, et al. Relevance of PSGL-1 Expression in B Cell Development and Activation. Front Immunol. 2020;11:588212 pubmed publisher |
| Oliveira J, Gandini M, Sales J, Fujimori S, Barbosa M, Frutuoso V, et al. Mycobacterium leprae induces a tolerogenic profile in monocyte-derived dendritic cells via TLR2 induction of IDO. J Leukoc Biol. 2021;110:167-176 pubmed publisher |
| Shevchenko J, Khristin A, Kurilin V, Kuznetsova M, Blinova D, Starostina N, et al. Autologous dendritic cells and activated cytotoxic T‑cells as combination therapy for breast cancer. Oncol Rep. 2020;43:671-680 pubmed publisher |
| Kubota S, Tokunaga K, Umezu T, Yokomizo Nakano T, Sun Y, Oshima M, et al. Lineage-specific RUNX2 super-enhancer activates MYC and promotes the development of blastic plasmacytoid dendritic cell neoplasm. Nat Commun. 2019;10:1653 pubmed publisher |
| Bi E, Li R, Bover L, Li H, Su P, Ma X, et al. E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. J Clin Invest. 2018;128:4821-4831 pubmed publisher |
| Halim T, Rana B, Walker J, Kerscher B, Knolle M, Jolin H, et al. Tissue-Restricted Adaptive Type 2 Immunity Is Orchestrated by Expression of the Costimulatory Molecule OX40L on Group 2 Innate Lymphoid Cells. Immunity. 2018;48:1195-1207.e6 pubmed publisher |
| Conrad C, Di Domizio J, Mylonas A, Belkhodja C, Demaria O, Navarini A, et al. TNF blockade induces a dysregulated type I interferon response without autoimmunity in paradoxical psoriasis. Nat Commun. 2018;9:25 pubmed publisher |
| Pierog P, Zhao Y, Singh S, Dai J, Yap G, Fitzgerald Bocarsly P. Toxoplasma gondii Inactivates Human Plasmacytoid Dendritic Cells by Functional Mimicry of IL-10. J Immunol. 2018;200:186-195 pubmed publisher |
| Macal M, Tam M, Hesser C, Di Domizio J, Léger P, Gilliet M, et al. CD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells. J Immunol. 2016;196:1900-9 pubmed publisher |
| Dai Y, Chen S, Kmieciak M, Zhou L, Lin H, Pei X, et al. The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair. Mol Cancer Ther. 2013;12:878-89 pubmed publisher |
| Labidi Galy S, Sisirak V, Meeus P, Gobert M, Treilleux I, Bajard A, et al. Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res. 2011;71:5423-34 pubmed publisher |
| Charles N, Hardwick D, Daugas E, Illei G, Rivera J. Basophils and the T helper 2 environment can promote the development of lupus nephritis. Nat Med. 2010;16:701-7 pubmed publisher |
| Martin Gayo E, Sierra Filardi E, Corbi A, Toribio M. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood. 2010;115:5366-75 pubmed publisher |
